Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular, Molecular, and Tumor Biology 27: DNA Methylation Inhibition

Antitumor activity of MG98, an antisense oligodeoxynucleotide targeting DNA methyltransferase-1 (DNMT1) in gastric carcinoma

Normand Beaulieu, Isabelle Dupont and A. Robert Macleod
Normand Beaulieu
MethylGene Inc., St. Laurent, PQ, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Dupont
MethylGene Inc., St. Laurent, PQ, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Robert Macleod
MethylGene Inc., St. Laurent, PQ, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2004
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 45, 2004

Abstract

1602

Gastric cancer remains a prevalent and difficult to treat form of cancer in humans. Altered patterns of DNA methylation are common in human tumors, as are elevated levels of the DNA-(cytosine-5)-methyltransferase enzymes DNMT1, DNMT3a and DNMT3b. Hypermethylation of CPG islands and resulting transcriptional inactivation of numerous growth regulator genes have been reported in human gastric cancer cells. Moreover, methylation mediated silencing of RUNX3 has recently been proposed as a causative event in the genesis of gastric cancer (Cell, Vol. 109, 113-124, (2002)) . Here we demonstrated that specific inhibition of one of the DNMT enzymes, the maintenance methyltransferase, DNMT1, in human gastric cancer cells, by the second generation antisense oligodeoxynucleotide (ODN) MG98, reactivates expression multiple methylation silenced tumor suppressor genes. Furthermore, MG98-induced depletion of DNMT1 in AGS, Kato III and MKN74 human gastric cancer cells in vitro resulted in significant growth inhibition concomitant with the re-expression of the silenced tumor suppressor genes p16ink4a and RUNX3. We also demonstrate that treatment of nude mice bearing MKN74 tumor xenografts resulted in tumor growth inhibition in vivo. These preclinical data support the role of DNA methylation in the maintenance of human gastric cancer and suggest that demethylating drugs such as MG98 may have utility in the treatment of human gastric cancer.

  • American Association for Cancer Research
Previous
Back to top
April 2004
Volume 64, Issue 7 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antitumor activity of MG98, an antisense oligodeoxynucleotide targeting DNA methyltransferase-1 (DNMT1) in gastric carcinoma
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Antitumor activity of MG98, an antisense oligodeoxynucleotide targeting DNA methyltransferase-1 (DNMT1) in gastric carcinoma
Normand Beaulieu, Isabelle Dupont and A. Robert Macleod
Cancer Res April 1 2004 (64) (7 Supplement) 369;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Antitumor activity of MG98, an antisense oligodeoxynucleotide targeting DNA methyltransferase-1 (DNMT1) in gastric carcinoma
Normand Beaulieu, Isabelle Dupont and A. Robert Macleod
Cancer Res April 1 2004 (64) (7 Supplement) 369;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • De novo DNA methyltransferase, DNMT 3b3, has an important biological attribution to oncogenesis
  • Mechanism of active DNA demethylation induced by the mood stabilizing and antiepileptic drug Valproic acid; implications for cancer
  • CpG hypermethylation is maintained in human cancer cells following RNAi-mediated depletion of DNMT1
Show more Cellular, Molecular, and Tumor Biology 27: DNA Methylation Inhibition
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement